Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.66-1.39 (-4.08%)
As of 10:01AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
35,000
0
Operating expenses
Research development
137,538
101,676
51,859
42,545
Selling general and administrative
120,478
71,792
29,465
16,694
Total operating expenses
258,016
173,468
81,324
59,239
Operating income or loss
-258,016
-173,468
-46,324
-59,239
Total other income/expenses net
-2,858
-1,140
-580
-2,614
Income before tax
-259,311
-173,910
-45,574
-58,306
Income from continuing operations
-259,311
-173,910
-45,574
-58,306
Net income
-259,311
-173,910
-45,574
-58,306
Net income available to common shareholders
-259,311
-173,910
-45,574
-50,577
Basic EPS
-
-3.59
-1.05
-3.81
Diluted EPS
-
-3.59
-1.05
-3.81
Basic average shares
-
48,498
43,300
13,275
Diluted average shares
-
48,498
43,300
13,275
EBITDA
-
-172,978
-45,975
-59,047